Dysregulation of cell adhesion and cell motility mechanisms have emerged as key elements in tumor progression and metastasis and it is notable that a large body of evidence details re-expression of both Eph and ephrin proteins at high levels in malignancies including melanoma and colon, gastric, breast, endometrial, and lung carcinomas [1,5]. This evidence concerns the gene EPHA1 and neoplasm.